# Ozonized In-office and Domiciliary Gels vs Chlorhexidine Gel 1% for the Management of Peri-implant Mucositis Sites

> **NCT05256914** · NA · COMPLETED · sponsor: **University of Pavia** · enrollment: 30 (actual)

## Conditions studied

- Peri-implant Mucositis

## Interventions

- **OTHER:** Ozoral Pro and Ozoral gel administration
- **OTHER:** Curasept chlorhexidine gel 1%

## Key facts

- **NCT ID:** NCT05256914
- **Lead sponsor:** University of Pavia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-27
- **Primary completion:** 2022-10-03
- **Final completion:** 2022-10-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05256914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05256914, "Ozonized In-office and Domiciliary Gels vs Chlorhexidine Gel 1% for the Management of Peri-implant Mucositis Sites". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05256914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*